InterMune jumps six percent after approval of lung disease drug

Silicon Valley biotech firm InterMune climbed over six percent today after reporting that the European Commission approved its drug to treat a deadly lung disease. http://dock-of-bay.blogspot.com/p/silicon-valley-2.html

 

itmn i got burned never again in this stock. was long got kill... at 10 bucks. then i shorted then it ripped to 38

 

IPF killed my Dad...and there where NO real drugs/treatment until this. Hope it works out.

 

I hope so too, Stok!